论文部分内容阅读
多沙唑嗪在治疗良性前列腺增生中性价比优良J Outcomes Research,1999,3:11-26.良性前列腺增生(BPH)的发生率将随着人口年龄的增加而提高,有更多男性就诊并接受治疗将加重医疗的负担。寻找有效的,有成本效益的的治疗药物将变得非常重要。Johnson等进行了一项研究,旨在评价α1肾
Doxazosin in the treatment of benign prostatic hyperplasia, the cost-effective J Outcomes Research, 1999,3: 11-26. The incidence of benign prostatic hyperplasia (BPH) will increase with the increase of the population age, more men see and accept Treatment will increase the medical burden. Finding effective, cost-effective therapies will become very important. Johnson conducted a study to evaluate α1 kidney